Poly-L-Lactic Acid (PLLA): Current Applications and Global Regulatory Landscape of a Regenerative Injectable Material
Against the backdrop of a rapidly growing regenerative medical aesthetics market, poly-L-lactic acid (PLLA) has long transcended the positioning of an ordinary filler material and become a globally recognized benchmark collagen-regenerative material in the field of facial rejuvenation. Unlike hyaluronic acid, which provides immediate physical volume replacement, PLLA is characterized by complete biodegradability and long-term stimulation of autologous collagen neogenesis. Over more than two decades of global clinical application, it has gradually built a reputation for both safety and long-term efficacy. With the recent acceleration of regulatory approvals for regenerative materials in China, clarifying its clinical progress and global regulatory framework is essential reference for industry practitioners and consumers alike.
View Details





